+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Phase 2
Age: 18Years - 70Years
All Genders
ID06967038

Phase 1-2 Study of CAR-NK Cell Therapy for High-risk Lymphoma Patients With Primary Sjogrens Syndrome

Led by Bangdong Gong · Updated on 2025-05-13

6

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating CAR-NK cell therapy in a phase I-II clinical trial for patients with high-risk lymphoma who also have primary Sjogrens syndrome pSS. The study aims to find the best dose of CAR-NK cells and assess how safe and effective increasing doses of iC9CAR19IL15 CB-NK cell therapy are. The trial uses an i33 dose escalation design to adjust the dose based on safety and response. Dose limiting toxicity DLT includes serious side effects like cytokine release syndrome, severe graft-versus-host disease, or allergic reactions after cell infusion. The study administers CAR-NK cells at three dose levels 5 106kg, 1 107kg, and 5 107kg of body weight. Researchers plan to enroll 6 to 12 participants. Dose adjustments may be made during the trial based on safety and tolerability data. If needed, the dose may be lowered or increased to find the best therapeutic level. The trial monitors participants closely for adverse events within 45 days after infusion. Participants will be monitored for safety outcomes such as the incidence and severity of dose limiting toxicities and other adverse events over 45 days. Researchers will also evaluate treatment efficacy by checking for reductions in lymphoma risk and improvements in dry mouth and eye symptoms at 30 days, with longer term efficacy monitored up to one year. Participants need to have normal cognitive function, consent to participate, and complete all trial procedures. The study runs until October 2027, involving ongoing safety and efficacy assessments.

CONDITIONS

Brief Title

Chimeric Antigen Receptor Natural Killer Cell Therapy for High-risk Lymphoma Patients With Primary Sjogren's Syndrome

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here